Dental Health Experts At Nationwide Children's Hospital Remind Parents About Scheduling Toddlers For Dental Visits
While infants under 12 months old may only have a few teeth, experts say they should been seen by a dentist within the first year of life. The American Academy of Pediatric Dentistry's revised guidelines on infant oral health recommend infants 6 to 12 months old should to be seen by a dentist. More than 40 percent of children have tooth decay by the time they reach kindergarten. In order to help prevent tooth decay, dental experts at Nationwide Children's Hospital are reminding parents to schedule dental appointments for their toddlers. Studies have shown that if children experience tooth decay in their baby teeth, they are more likely to develop tooth decay in their permanent teeth. By bringing their child to a dentist at an early age, parents learn about the structure of the child's mouth, preventative information on infant oral health and introduce their toddlers to the act of brushing their teeth.
Nearly 20 million Americans annually visit a dentist but not a general healthcare provider, according to an NYU study published in the American Journal of Public Health. The study, conducted by a nursing-dental research team at NYU, is the first of its kind to determine the proportion of Americans who are seen annually by a dentist but not by a general healthcare provider. This finding suggests dentists can play a crucial role as health care practitioners in the front-line defense of identifying systemic disease which would otherwise go undetected in a significant portion of the population, say the researchers. "For these and other individuals, dental professionals are in a key position to assess and detect oral signs and symptoms of systemic health disorders that may otherwise go unnoticed, and to refer patients for follow-up care, " said Dr.
Clinicians need a protocol to reduce the risk of substantial bleeding after dental extractions in cardiac patients who take anticoagulant medications. Findings in a study published in the current issue of the Journal of Oral Implantology reveal that the use of leukocyte- and platelet-rich fibrin biomaterial, a material commonly used in dentistry to improve healing and tissue regeneration, is a safe filling and haemostatic material after dental extractions. Researchers assessed the use of the biomaterial in 50 heart patients who received oral anticoagulant therapy with warfarin after a mechanical valve substitution. It is not recommended to substitute anticoagulant therapy with heparin prior to minor surgery, even though the risk of postoperative bleeding could potentially be controlled.
Allowing a patient to be comfortable and pain-free during surgical and restorative dental procedures is an essential part of the process. The most commonly used local anesthetic injection for lower teeth is the inferior alveolar nerve (IAN) block. However, failure rates ranging from 10 to 39 percent have been reported. The current issue of the journal Anesthesia Progress presents a study testing the efficacy of adding a solution of mannitol to the anesthetic typically used in IAN blocks. Forty adult subjects participated in the study, receiving an IAN block at each of three separate appointments at least one week apart. The study compared the effectiveness of the standard anesthetic, lidocaine with epinephrine, to the effectiveness of two different volumes of lidocaine with epinephrine plus 0.
A common oral bacteria, Fusobacterium nucleatum, acts like a key to open a door in human blood vessels and leads the way for it and other bacteria like Escherichia coli to invade the body through the blood and make people sick, according to dental researchers at Case Western Reserve University. Yiping Han, professor of periodontics at the Case Western Reserve School of Dental Medicine, made the discovery in her continued work with the Fusobacterium nucleatum bacterium, one of the most prevalent of the more than 700 bacteria in the mouth. She found the gram-negative anaerobe has a novel adhesin or bonding agent she's named FadA that triggers a cascade of signals that break the junctures in an interlocking sheath of endothelial cells on blood vessel's surface just enough to allow F. nucleatum and other bacteria into the blood.